Developmental programming of type 2 diabetes-molecular mechanisms and clinical implications

Project: Research

Project Details

Description

Low birthweight (LBW) is an established risk factor of type 2 diabetes (T2D), and recent data from our group suggest that LBW in T2D in addition is associated with a more severe disease course including earlier diagnosis compared with patients with normal or high birthweight. These findings are paradigm shifting, as they extend the role of LBW from being “only” a T2D risk factor, to a factor of high importance for the clinical presentation, care as well as treatment of the individual T2D patient. We now in this Crafoord funded project aim to trace original birthweight information of > 15.000 T2D patients from the ANDIS cohort, and via linkage to registries determine the extent to which LBW in T2D is associated with a more severe disease course including more complications and premature death.
StatusFinished
Effective start/end date2024/05/012025/04/30

Funding

  • Crafoord Foundation

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Subject classification (UKÄ)

  • Endocrinology and Diabetes